Insulin/IGF resistance in AD brain results in decreased phosphoinositol-3-kinase (PI3K)/Akt [23,24] and increased activation of glycogen synthase kinase 3β (GSK-3β). The gene discussed is AKT1; the disease is Alzheimer disease.